Wnt family member 2 mRNA (WNT2 mRNA) (WNT2 mRNA)

Wnt family member 2 (WNT2) mRNA is the transcript of the WNT2 gene, which encodes a secreted glycoprotein involved in the canonical Wnt/beta-catenin signaling pathway. This pathway is essential for regulating cell fate, proliferation, and embryonic development, particularly in the formation of the lungs and placenta (UniProt P09544). In many human cancers, such as colorectal, esophageal, and non-small cell lung cancer, WNT2 mRNA is significantly upregulated, acting as an oncogene that drives tumor progression and metastasis (PubMed 21858224). Therapeutic strategies targeting WNT2 mRNA, such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs), aim to degrade the transcript or block its translation, thereby reducing the levels of the WNT2 protein (PubMed 11544116). By silencing WNT2 at the pre-translational level, these interventions can effectively inhibit the hyperactive Wnt signaling that characterizes many aggressive tumors. Although currently largely in the experimental and preclinical phases, targeting WNT2 mRNA offers a precise method to modulate a pathway that has historically been difficult to target with small molecule inhibitors.

Other names

Wingless-type MMTV integration site family member 2 mRNAIRP mRNAINT1L1 mRNA

RNA interference (RNAi) or antisense inhibition leading to the degradation of the mRNA transcript and subsequent reduction in WNT2 protein synthesis.